ORCA seeks to establish value-creating strategic alliances with academic and commercial partners in the areas of development, manufacturing, and commercialization of new virotherapies for cancer.
ORCA has research collaborations with the department of Medical Oncology of the VU University Medical Center, Amsterdam, the Netherlands; the translational research laboratory of Institut Català d’Oncologia (ICO), Barcelona, Spain; and Radboud University Medical Center Nijmegen (RadboudUMC), The Netherlands.
